mifepristone has been researched along with letrozole in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 4 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Garfield, RE; Given, RL; Shi, L; Shi, SQ; von Hertzen, H | 1 |
| Croxatto, HB; Garfield, R; Ortiz, ME; Ortiz, RE; Zepeda, AJ | 1 |
| Ho, PC; Lee, VC; Ng, EH; Tang, OS; Yeung, WS | 1 |
| Chai, J; Ho, PC | 1 |
| Chen, Y; Luo, J; Qi, Q; Wang, Y; Xie, Q | 1 |
| Diao, WY; Du, L; Du, YH; Gemzell-Danielsson, K; Ho, PC; Li, RHW; Zhang, L | 1 |
| Frye, LJ; Gawron, LM; Kaiser, JE; Sexsmith, CD; Shochet, T; Turok, D; Winikoff, B | 1 |
| Luo, J; Qi, Q; Wang, Y; Xia, Y; Xie, Q | 1 |
2 review(s) available for mifepristone and letrozole
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Synergistic effects of antiprogestins and iNOS or aromatase inhibitors on establishment and maintenance of pregnancy.
Topics: Animals; Aromatase Inhibitors; Embryo Implantation; Enzyme Inhibitors; Estrogens; Female; Hormone Antagonists; Humans; Immunohistochemistry; Letrozole; Mifepristone; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitriles; Pregnancy; Progestins; Rats; Time Factors; Triazoles | 2003 |
3 trial(s) available for mifepristone and letrozole
| Article | Year |
|---|---|
A pilot study on the use of letrozole with either misoprostol or mifepristone for termination of pregnancy up to 63 days.
Topics: Abortifacient Agents; Abortion, Induced; Adolescent; Adult; Estradiol; Female; Humans; Hydrocortisone; Letrozole; Mifepristone; Misoprostol; Nitriles; Pilot Projects; Pregnancy; Pregnancy Trimester, First; Progesterone; Triazoles; Young Adult | 2011 |
Prospective open-label non-inferiority randomised controlled trial comparing letrozole and mifepristone pretreatment in medical management of first trimester missed miscarriage: study protocol.
Topics: Abortion, Induced; Abortion, Spontaneous; Female; Humans; Letrozole; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Prospective Studies; Randomized Controlled Trials as Topic; Treatment Outcome | 2022 |
Cocktail treatment by GnRH-antagonist, letrozole, and mifepristone for the prevention of ovarian hyperstimulation syndrome: a prospective randomized trial.
Topics: Estradiol; Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Letrozole; Mifepristone; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Prospective Studies | 2023 |
5 other study(ies) available for mifepristone and letrozole
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Progesterone, but not luteal estrogen, is required for the establishment of pregnancy in the new world monkey Cebus apella.
Topics: Animals; Aromatase Inhibitors; Cebus; Embryo Implantation; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Letrozole; Luteal Phase; Male; Mifepristone; Nitriles; Pregnancy; Pregnancy Rate; Pregnancy, Animal; Progesterone; Triazoles | 2007 |
A pilot study on the combined use of letrozole, mifepristone and misoprostol in termination of first trimester pregnancy up to 9 weeks' gestation.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Aromatase Inhibitors; Female; Humans; Letrozole; Mifepristone; Misoprostol; Nitriles; Pilot Projects; Pregnancy; Triazoles | 2013 |
Effect of GnRH-antagonist, mifepristone and letrozole on preventing ovarian hyperstimulation syndrome in rat model.
Topics: Animals; Aromatase Inhibitors; Caspase 3; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Gonadotropin-Releasing Hormone; Interleukin-6; Letrozole; Mifepristone; Ovarian Hyperstimulation Syndrome; Ovary; Progesterone; Random Allocation; Rats, Wistar; Vascular Endothelial Growth Factor A | 2021 |
Single dose letrozole and misoprostol for termination of pregnancy through 63 days' gestation: A pilot study.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Administration, Intravaginal; Female; Humans; Letrozole; Mifepristone; Misoprostol; Pilot Projects; Pregnancy | 2023 |